Metformin Adjunct With Antineoplastic Agents for the Treatment of Lung Cancer: A Meta-Analysis of Randomized Controlled Trials and Observational Cohort Studies

Objective: Resistance to anticancer agents ensures a poor prognosis in patients with lung cancer. Metformin could enhance the anticancer effects of standard antineoplastic agents [traditional chemotherapy drugs, epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), or immune check...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xiaofeng, Chen, Xi, Wang, Lin, Yang, Bowen, Cai, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209491/
https://www.ncbi.nlm.nih.gov/pubmed/34149406
http://dx.doi.org/10.3389/fphar.2021.639016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209491/
https://www.ncbi.nlm.nih.gov/pubmed/34149406
http://dx.doi.org/10.3389/fphar.2021.639016

Ejemplares similares